Oxford Gene Technology (OGT) — provider of genetics research solutions — has announced it is directly selling Cytocell Fluorescence In Situ Hybridisation (FISH) products through several established affiliates of Sysmex in Europe, following its acquisition last year.
Helping hand
Since the acquisition, both companies have been working on developing commercial and product synergies across their portfolios with a strong focus on growth in molecular diagnostics. Additionally, the companies are collaborating to develop an automated FISH testing system.
“We’re delighted that our Cytocell customers can now access the benefits of the excellent Sysmex sales and support services in Europe,” commented Spencer Howell, executive VP sales at OGT. “Sysmex is committed to growing our Cytocell portfolio with new products and by combining its expertise in instrumentation with ours in FISH probe design. Providing our products through the large, experienced, Sysmex sales network and excellent support infrastructure will enable us to grow the business in new areas — namely molecular diagnostics — to provide even more innovative products and solutions for our customers.”
OGT anticipates it will also sell its CytoSure microarray and SureSeq next generation sequencing (NGS) product portfolio through Sysmex in the near future